Generate a tailored SOP for Dr. Clancy Mullan. Improve your application with a focused, well-structured draft.
Raised in Raleigh, North Carolina, Clancy Mullan attended the University of North Carolina at Chapel Hill, where he earned undergraduate degrees in Chemistry (Biochemistry, with Honors Distinction) and Traditional Mathematics. He worked in the Department of Genetics under Dr. Mark Heise, focusing on non-coding complementary strand transcription products of alphaviruses and validating methodology for producing sequence-independent cDNA libraries for multiple RNA viruses. He later attended the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, where he studied the role of nicotinic signaling in mitochondrial membrane preservation during ischemic preconditioning under Dr. Kaie Ojamaa. Mullan was selected for Alpha Omega Alpha and received a graduation award from the Department of Thoracic and Cardiovascular Surgery in 2018. He joined the Yale Integrated Thoracic Surgery program and has produced numerous outcome research publications utilizing institutional, national, and international databases. Mullan completed his PhD in Investigative Medicine in 2024, with mentorship from Dr. Jordan Pober, focusing on alloreactivity and microRNA-mediated regulation of endothelial cytokine expression. He plans to pursue a career in surgical heart failure and has been awarded the 2024 Yale Department of Surgery Surgeon-Scientist Training Program to continue his translational science program.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.